m923
Generic: adalimumab biosimilar
m923: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| MOMENTA PHARMACEUTICALS INC (MNTA) | BLA Filed |
Get deeper analysis on m923
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis